Canadian Warrants

Quick Links:
Back to Home Page              Back to Warrant Sheets             Back to Expired Warrants

Address: 250 Elm St
Aylmer ON Canada N5H 2M8
Phone: 844 933 3636
Fax: 844 933 3637
Web Site: http://www.weedmd.com

Warrant Symbol - WMD.WT.A
Number  Trading - 19,046,875
Expiration Date - March 12, 2023
Cusip - 948525 14 2
Exercise Price - $0.60
 
Warrant Symbol - WMD.WT
Number  Trading - 8,196,875
Expiration Date - September 25, 2022
Cusip - 948525 13 4
Exercise Price - $1.80

Warrants called to trade news:




WeedMD name change to Entourage Health

2021-07-14 16:53 ET - Change Name

Pursuant to a resolution passed by shareholders on June 30, 2021, the company has changed its name as follows. There is no consolidation of capital.

Effective at the opening, Friday, July 16, 2021, the common shares, convertible debentures and warrants of Entourage Health Corp. will commence trading on the TSX Venture Exchange, and the common shares, convertible debentures and warrants of WeedMD Inc. will be delisted. The company is classified as a pharmaceutical and medicine manufacturing company.

Warrants

Trading symbol: ENTG.WT (new)
Cusip No.: 293861 12 6 (new)
Trading symbol: ENTG.WT.A (new)
Cusip No.: 293861 11 8 (new)

© 2022 Canjex Publishing Ltd. All rights reserved.

WeedMD prospectus offering, warrant listing

2021-03-26 15:59 ET - Prospectus Approved

Effective at the opening, Tuesday, March 30, 2021, the common share purchase warrants of the company will commence trading on the TSX Venture Exchange. The company is classified as a pharmaceutical and medicine manufacturing company.

Corporate jurisdiction: Ontario

Capitalization: up to 19,046,875 warrants created and authorized, of which 17,968,750 are issued and outstanding
Trading symbol: WMD.WT.A
Cusip No.: 948525 14 2

These warrants were issued under a warrant indenture dated March 12, 2021, pursuant to the company's short form prospectus dated March 8, 2021. Each warrant entitles the holder to purchase one common share of the company at a price of 60 cents until March 12, 2023.

If, at any time after March 12, 2022, and prior to March 12, 2023, the daily volume weighted average trading price of the common shares on the TSX Venture Exchange is equal to or greater than 96 cents for 10 consecutive trading days, the company may, within 10 days of the occurrence of such event, provide written notice to the holders of the warrants and the warrant agent, supplemented by way of a news release, accelerating the expiry date of the warrants from the warrant expiry date to the date that is 30 days following the date of such notice. Any unexercised warrants will automatically expire on the accelerated expiry date in accordance with the warrant indenture.

© 2022 Canjex Publishing Ltd. All rights reserved.

WeedMD closes $13.11-million bought deal

2019-09-25 07:58 MT - News Release

Each warrant entitles the holder thereof to purchase one common share in the capital of the company at an exercise price of $1.80 until Sept. 25, 2022. Provided that, if at any time prior to the expiry date of the warrants, the volume-weighted average trading price of the common shares on the TSX Venture Exchange is greater than $3.60 for 20 consecutive trading days, the company may, within 10 business days of the occurrence of such event, deliver a notice (including a press release) to the holders of warrants accelerating the expiry date of the warrants to the date that is 30 days following the date of such notice.

Effective at the opening, Friday, Sept. 27, 2019, the common share purchase warrants of the company will commence trading on the TSX Venture Exchange.

Capitalization: 8,196,875 issued and outstanding
Trading symbol: WMD.WT
Cusip No.: 948525 13 4

These warrants were issued under a warrant indenture dated Sept. 25, 2019, pursuant to the company's short form prospectus dated Sept. 18, 2019. Each warrant entitles the holder to purchase one common share of the company at a price of $1.80 per share until September 25, 2022.

© 2019 Canjex Publishing Ltd. All rights reserved.